Industry News
Blood test may differentiate between benign lung nodules and early stage lung cancer
Oct 18, 2013
Indi (Integrated Diagnostics), an emerging leader in molecular diagnostics, today announced the results of a major study which suggests that quantifying a combination of blood proteins can distinguish between benign lung nodules and early-stage lung cancer with high probability... Read More
Scientists identify genetic errors in 12 major cancer types
Oct 18, 2013
Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments. The research, published Oct... Read More
Every woman's right: Breast Reconstruction Awareness (BRA) Day marked with team approach
Oct 18, 2013
Thousands of board certified plastic surgeons, including the plastic surgeon who performed Angelina Jolie's breast reconstruction, are joining forces with breast centers, support groups and breast cancer survivors to send a powerful message... Read More
Hormones in BRCA gene carriers 'explain cancer risk'
Oct 18, 2013
A new study suggests that abnormal levels of female hormones in the bloodstream may be a reason why women with faulty BRCA1 and BRCA2 genes are more likely to develop breast and ovarian cancer over other cancers... Read More
Potential rapid bedside blood test for sepsis
Oct 17, 2013
Researchers are hopeful they have discovered a biomarker or biological footprint for sepsis that could form the basis of a rapid bedside blood test that returns results within 2 hours instead of the 2 days required by current diagnostics. The team, led by King's College London in the UK, reports the discovery in the latest online issue of the journal PLOS ONE... Read More
Potential rapid bedside blood test for sepsis
Oct 17, 2013
Researchers are hopeful they have discovered a biomarker or biological footprint for sepsis that could form the basis of a rapid bedside blood test that returns results within 2 hours instead of the 2 days required by current diagnostics. The team, led by King's College London in the UK, reports the discovery in the latest online issue of the journal PLOS ONE... Read More
Cabbage compound protects healthy tissue from radiation damage
Oct 17, 2013
A team of US researchers has discovered that an anti-cancer compound present in cruciferous vegetables, such as cabbage, cauliflower and broccoli, also protects rodents from lethal doses of radiation... Read More
Anti-cancer virus activated by drug
Oct 17, 2013
Parvoviruses cause no harm in humans, but they can attack and kill cancer cells. Since 1992, scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been studying these viruses with the aim of developing a viral therapy to treat glioblastomas, a type of aggressively growing brain cancer... Read More
MicroRNAs tackle cancer metastasis
Oct 17, 2013
A class of molecules called microRNAs may offer cancer patients two ways to combat their disease. Researchers at Princeton University have found that microRNAs - small bits of genetic material capable of repressing the expression of certain genes - may serve as both therapeutic targets and predictors of metastasis, or a cancer's spread from its initial site to other parts of the body... Read More
Anti-cancer virus activated by drug
Oct 17, 2013
Parvoviruses cause no harm in humans, but they can attack and kill cancer cells. Since 1992, scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been studying these viruses with the aim of developing a viral therapy to treat glioblastomas, a type of aggressively growing brain cancer... Read More
Previous Page Next Page